NCT03455907已完成不适用
Evaluation of the Frequency of Occurrence of Joint Pain With Bevacizumab in Patients With Ovarian, Colorectal or Bronchopulmonary Cancer
University Hospital, Lille2 个研究点 分布在 1 个国家目标入组 71 人开始时间: 2018年1月3日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 71
- 试验地点
- 2
- 主要终点
- Frequency of arthralgia
研究概览
简要总结
Self-administered questionnaire survey to determine the presence or absence of joint pain during bevacizumab treatment for lung, ovarian, colorectal cancers.
The principal end-point is the frequency of arthralgia after 6 months of treatment with Bevacizumab.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient with ovarian, colorectal or lung cancer receiving bevacizumab therapy
- •Male or female (aged ≥18 years old)
- •Performance Status (PS) between 0 and 2
- •Expected life> 3 months
- •Ability to answer a self-questionnaire
- •Obtaining the non-opposition of patient participation
排除标准
- •Pregnant or lactating woman
- •Rapid evolution of neoplastic pathology
- •Major cognitive disorders that do not allow filling of the self-questionnaire
- •Impossibility to submit to medical monitoring for social, psychological or geographical reasons
- •Patients under guardianship or curatorship
研究组 & 干预措施
Patients
patients with ovarian, colorectal or bronchopulmonary cancer receiving Bevacizumab
结局指标
主要结局
Frequency of arthralgia
时间窗: At 6 months
Frequency of joint manifestations of any grade according to the CTCAE (Common Terminology Criteria for Adverse Events) scale version 4.0 observed between the start of bevacizumab treatment and 6 months of treatment.
次要结局
- correlation between global cancer response and occurrence of arthralgia(baseline, at 3 months, at 6 months)
- auto questionnaire specific to the study(Baseline at 3 months, at 6 months)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Association Between Clinical Signs and MRI Findings of the Lumbar Facet JointsLow Back PainFacet Joint PainNCT01628939Christoph Maier, Prof. Dr.150
进行中（未招募）
1 期
Joint pain personalised treatment assessment to investigate the acceptability of modified release oxycontin for managing chronic pain in patients with osteoarthritis of the hip - Joint Pain PTAHip OsteoarthritisEUCTR2005-004527-19-GBMRC Health Services Research Collaboration20
Unknown
不适用
Human Physiology and Self-Reported Pain ScoreCancer PainNCT04053608Taichung Veterans General Hospital20
已完成
不适用
Gait Modification Treatments for Knee PathologyKnee InjuriesKnee OsteoarthritisNCT03116230Stanford University38
招募中
1 期
Clinical observation on the treatment of joint swelling and pain due to the Fengtabuzu syndrome of RA by Dai medicine LongmengshahousaRAITMCTR2100004644Yunnan Hospital of Traditional Chinese Medicine